Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY   SUMMER 2011 , Volume 5 , Number SUPPLEMENT 1; Page(s) 59 To 60.
 
Paper: 

EPIDEMIOLOGY AND ETHICS: STUDY OF CETRORELIX IN INHIBITION OF SIDE EFFECT OF VINBLASTIN USED IN CHEMOTHERAPY ON GERMINAL EPITHELIUM IN MOUSE TESTIS

 
 
Author(s):  MOHAMMADNEJAD D.*, EBRAHIM S., RAMEZANI M., HAMZEZADE A., MOHAMMADI ROSHANDEH A., AKHTARI SHOJAEI E., EBRAHIMI KALAN A.
 
* DRUG APPLIED RESEARCH CENTER, FACULTY OF MEDICAL SCIENCE, TABRIZ UNIVERSITY, TABRIZ, IRAN
 
Abstract: 

Background: Infertility problem affects young couples. One of the known causes of spermatogenic disorder is chemotherapy in patients with cancer. Since dividing cells are mainly affected by anticancer drugs, the aim of the present study is to investigate the preventive effect of GnRH on spermatogenic defect produced by anticancer drug.
Materials and Methods: In the present study 30 adult female mice aging 6-8 weeks were used. The mice were divided into 3 equal groups as control, exp group 1 and exp group 2. In exp group 1vinblastin was injected as ip for 5 days at 0. 25 mg/kg. In exp group 2 group cetrorelix injection was started one week before vinblastin treatment and continued for 3 more weeks. The mice in all groups were sacrificed 3 weeks after the last dose of Cetrorelix injection. Testicular specimens were prepared for LM studies.
Results: Microscopic study revealed that in the control group the mean number of sertoli and spermatogonium, were 8.20 ± 1.30 and 56 ± 7.35 respectively. In exp group 1 the mean numbers of above mentioned cells were 18.60 ± 3.65 and 39.80 ± 3.70. In exp group 2 the mean numbers of above mentioned cells were 9.20 ± 1.3 and 54.80 ± 4.95. The data showed the difference between control and exp 1group was significant, but the difference between control and exp 2 was not. Spermatogenesis index (SI) and diameter of germinal epithelium in control group were 0.70 ± 0.30 and 168.80 ± 14.13 respectively. In exp group 1 were 0.17 ± 0.16 and 117.80 ± 14.18 but in exp group 2 were 0.62 ± 0.25 and 161.20 ± 12.21. The data showed the difference between control and exp 1group was significant, but the difference between control and exp 2 was not.
Conclusion: It is concluded that GnRH antagonist administration before cancer treatment could prevent the side effect of anticancer drugs.

 
Keyword(s): ANTICANCER DRUG, GNRH ANTAGONIST, CHEMOTHERAPY, CETRORELIX
 
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

MOHAMMADNEJAD, D., & EBRAHIM, S., & RAMEZANI, M., & HAMZEZADE, A., & MOHAMMADI ROSHANDEH, A., & AKHTARI SHOJAEI, E., & EBRAHIMI KALAN, A. (2011). EPIDEMIOLOGY AND ETHICS: STUDY OF CETRORELIX IN INHIBITION OF SIDE EFFECT OF VINBLASTIN USED IN CHEMOTHERAPY ON GERMINAL EPITHELIUM IN MOUSE TESTIS. INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY, 5(SUPPLEMENT 1), 59-60. https://www.sid.ir/en/journal/ViewPaper.aspx?id=272724



Vancouver: Copy

MOHAMMADNEJAD D., EBRAHIM S., RAMEZANI M., HAMZEZADE A., MOHAMMADI ROSHANDEH A., AKHTARI SHOJAEI E., EBRAHIMI KALAN A.. EPIDEMIOLOGY AND ETHICS: STUDY OF CETRORELIX IN INHIBITION OF SIDE EFFECT OF VINBLASTIN USED IN CHEMOTHERAPY ON GERMINAL EPITHELIUM IN MOUSE TESTIS. INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY. 2011 [cited 2021July30];5(SUPPLEMENT 1):59-60. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=272724



IEEE: Copy

MOHAMMADNEJAD, D., EBRAHIM, S., RAMEZANI, M., HAMZEZADE, A., MOHAMMADI ROSHANDEH, A., AKHTARI SHOJAEI, E., EBRAHIMI KALAN, A., 2011. EPIDEMIOLOGY AND ETHICS: STUDY OF CETRORELIX IN INHIBITION OF SIDE EFFECT OF VINBLASTIN USED IN CHEMOTHERAPY ON GERMINAL EPITHELIUM IN MOUSE TESTIS. INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY, [online] 5(SUPPLEMENT 1), pp.59-60. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=272724.



 
 
Yearly Visit 24
 
 
Latest on Blog
Enter SID Blog